SLSN

Solesence, Inc. Common Stock
NASDAQCONSUMER DEFENSIVEHOUSEHOLD & PERSONAL PRODUCTS

Key Statistics

Market Cap
$64.30M
P/E Ratio
91.03
EPS
$0.01
Beta
1.31
52W High
$4.55
52W Low
$0.61
50-Day MA
$1.05
200-Day MA
$1.60
Dividend Yield
Profit Margin
1.56%
Forward P/E
11.36
PEG Ratio

About Solesence, Inc. Common Stock

Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company is headquartered in Romeoville, Illinois.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$60.40M
Gross Profit (TTM)$16.02M
EBITDA$1.80M
Operating Margin-3.89%
Return on Equity5.88%
Return on Assets0.97%
Revenue/Share (TTM)$0.86
Book Value$0.24
Price-to-Book3.90
Price-to-Sales (TTM)1.06
EV/Revenue1.456
EV/EBITDA29.14
Quarterly Earnings Growth (YoY)-93.50%
Quarterly Revenue Growth (YoY)-11.40%
Shares Outstanding$70.63M
Float$18.32M
% Insiders73.11%
% Institutions6.25%

Historical Volatility

HV 10-Day
170.57%
HV 20-Day
133.48%
HV 30-Day
142.31%
HV 60-Day
129.33%
HV Rank
96.8%

Volatility is currently expanding

Latest News

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.

GlobeNewsWire7/28/2026Neutral
Solésence Reports First Quarter 2026 Financial Results

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026.

GlobeNewsWire5/12/2026Neutral
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date.

GlobeNewsWire4/28/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SLSN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

Data last updated: 7/29/2026